Depression · People with temporomandibular disorders (TMD)
Occlusal splint showed no clear difference in depression compared with physical therapy (ultrasound, exercise, sensorimotor training,…; GRADE not reported.
1 finding from 1 review
Depression · People with temporomandibular disorders (TMD)
Occlusal splint led to lower depression compared with no treatment or placebo (non-occlusal or transparent-foil placebo…; GRADE not reported.
1 finding from 1 review
Depression · Adults (general population)
Meta-analysis of observational studies (higher vs lower 25(OH)D) for Depression (Cohort studies): HR 0.44 (95% CI 0.27 to 0.72), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.
2 findings from 1 review
Depression (long term) · Adults over 18 years of age with chronic orofacial pain (temporomandibular disorder (TMD))
Psychosocial interventions (cognitive behavioural therapy,… led to lower depression (long term) compared with usual care (conservative treatment: education, counselling,…; GRADE not reported.
1 finding from 1 review
Depression (short term) · Adults over 18 years of age with chronic orofacial pain (temporomandibular disorder (TMD))
Hypnosis led to lower depression (short term) compared with relaxation; GRADE not reported.
1 finding from 1 review
Depressive symptoms · Patients with pain dysfunction syndrome (PDS) of all degrees of severity
Stabilisation splint (SS) led to lower depression (CES-D, POMS) compared with minimal/no treatment; GRADE not reported.
1 finding from 1 review
MD -3.90 [-6.29, -1.52]
1 study
GRADE not reported
Depressive symptoms · Patients with pain dysfunction syndrome (PDS) of all degrees of severity
Stabilisation splint (SS) led to higher depression (CES-D, POMS) compared with biofeedback/stress management; GRADE not reported.
1 finding from 1 review
MD 5.50 [1.49, 9.51]
1 study
GRADE not reported
Change in QoL - depression (surrogate marker) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether benzodiazepines (systemic clonazepam) changes change in QoL - depression (surrogate marker) compared with placebo (very low certainty).
1 finding from 1 review
Change in QoL - depression (surrogate marker) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether dietary supplements (lycopene) changes change in QoL - depression (surrogate marker) compared with placebo (very low certainty).
1 finding from 1 review
Change in QoL - depression (surrogate marker) · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptoms
It is very uncertain whether physical barriers (tongue protector) changes change in QoL - depression (surrogate marker) compared with placebo (very low certainty).
1 finding from 1 review